The secret DNA circles fueling pancreatic cancer’s aggression
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of…
Browsing: Featured
Is red wine a healthier choice than white wine? Uncorking the cancer risks
A common perception is that not all alcoholic beverages are alike. Red wine, for instance,…
S3E2 The Oncology Journal Club: Is DEI Dead? The Future of Diversity, Equity and Inclusion in Healthcare
Welcome to Episode 2 of the third series of The Oncology Journal Club. Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to digest how political changes in the US will have a wider impact on oncology care and research globally.
Research by scientists upends scientific understanding of how anticancer drugs kill cancer
Research by UMass Chan Medical School scientists Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses…
Scientists discover the ‘roadmap’ that aggressive cancer uses to spread around the body
Scientists have discovered a new way to predict which tumours will become aggressive before they…
S3E1 The Oncology Journal Club: ASCO GI Highlights 2025
Welcome to Episode 1 of the Third Series of The Oncology Journal Club! Our Hosts Professor Craig Underhill and Professor Christopher Jackson are joined by Professor Chris Karapetis to unpack the ASCO GI 2025 meeting.
A self-assembling nanoplatform for enhanced cancer photoimmunotherapy
Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and destroy…
Text message tool addresses “time toxicity” for cancer patients
Cancer patients spend a lot of time on their care. Meeting with doctors and other…
Chemo-immunotherapy approach shows potential benefit in patients with advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Centre, USA, demonstrated the potential of…
New technique to measure circulating tumour DNA in metastatic cancer may improve disease progression surveillance and patient outcomes
In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumour DNA (ctDNA) may be…